Home » Topics » Disease categories and therapies » Immune

Immune
RSS

MacroGenics acquires Eliance, forms alliance with UT Southwestern

June 14, 2002

GSK to evaluate BioVex's ImmunoVEX vaccine platform

June 12, 2002

Sankyo describes Th1-selective immunosuppressants

June 11, 2002

American Biogenetic Sciences seeks partners for oral smallpox vaccine

June 10, 2002

TH-9507 improves immune function in the elderly

June 10, 2002

FluINsure cleared for phase II testing in influenza

June 7, 2002

Patient dosing completed in phase II trial of C. jejuni vaccine

June 5, 2002

New rapamycin analogues as potential immunosuppressants

June 5, 2002

Cyclophilin-binding compound with immunomodulating, antiasthmatic and antiinflammatory effects

June 4, 2002

Endocyte licenses Galenica's GP-0100 for vitamin-based cancer treatments

June 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....